About: Andrea Antinori

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Andrea Antinori Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Italian infectiologist (1957-)

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідник (uk) 研究者 (zh) հետազոտող (hy) Italian infectiologist (1957-) (en) infettivologo italiano (1957-) (it)
rdfs:label	Andrea Antinori (de) Andrea Antinori (en) Andrea Antinori (es) Andrea Antinori (fr) Andrea Antinori (it) Andrea Antinori (nl) Andrea Antinori (pt) Andrea Antinori (sl) Andrea Antinori (tr) Andrea Antinori (pt-br) Andrea Antinori (ast)
skos:prefLabel	Andrea Antinori (de) Andrea Antinori (en) Andrea Antinori (es) Andrea Antinori (fr) Andrea Antinori (it) Andrea Antinori (nl) Andrea Antinori (pt) Andrea Antinori (sl) Andrea Antinori (tr) Andrea Antinori (pt-br) Andrea Antinori (ast)
name	Andrea Antinori (de) Andrea Antinori (en) Andrea Antinori (es) Andrea Antinori (fr) Andrea Antinori (it) Andrea Antinori (nl) Andrea Antinori (pt) Andrea Antinori (sl) Andrea Antinori (tr) Andrea Antinori (pt-br) Andrea Antinori (ast)
Scopus author ID	wds:Q62568867-511B90D5-317E-4FE4-B9DB-460F0D3E78CA
Scopus author ID	7005824555
given name	wds:q62568867-0b91613c-4133-f63d-c3c9-171bb3c82a50
given name	Andrea
instance of	wds:Q62568867-43B1AE6C-44C2-486A-A1CE-B9C91C25193A
instance of	Homo sapiens
work location	wds:Q62568867-38B61335-1125-4798-85EA-A281B5663F94
work location	Rome
occupation	wds:Q62568867-90942AD6-133A-425A-A901-3AEDC8C09375
employer	wds:Q62568867-31AB1A65-67F9-4978-A03D-622F167B6062
languages spoken, written or signed	wds:q62568867-125eafb4-4dee-4b9a-bfb3-fc57c089a0fd wds:q62568867-fac879bc-4f38-5194-6931-b6c0814ea8f1
place of birth	wds:q62568867-a40f0674-4876-1c54-78cb-8e1a5da9925c
sex or gender	wds:q62568867-28b4036f-447d-65db-b882-60aea821ea14
VIAF ID	wds:Q62568867-0558551e-4151-a676-c09e-8eb04b0a79e9
country of citizenship	wds:q62568867-63d73c36-44d1-b82b-b34d-83e936d23043
SBN author ID	wds:Q62568867-6894E786-2DF5-40D7-9D1D-F80941686955
date of birth	wds:Q62568867-8dd7557c-4230-5e94-458b-628e4737f898
family name	wds:q62568867-40788cae-410a-9497-9172-238448a0e071
WorldCat Identities ID (superseded)	wds:q62568867-437e6109-4045-6608-fdbf-306595a2741f
VIAF ID	http://viaf.org/viaf/90358816
occupation	infectious disease physician
employer	Università degli Studi Roma Tre
languages spoken, written or signed	English Italian
place of birth	Rome
sex or gender	male
VIAF ID	90358816
country of citizenship	Italy
SBN author ID	SBNV016442
date of birth	1957-01-01 00:00:00Z (xsd:dateTime)
family name	Antinori
WorldCat Identities ID (superseded)	viaf-90358816
ORCID iD	wds:Q62568867-4077254C-79A8-41BF-9C22-CB054DAD5FF9
Dimensions author ID	wds:Q62568867-6DA698A3-2215-48CE-AE80-91A5FA78B0B3
ORCID iD	https://orcid.org/0000-0003-2121-4684
ORCID iD	0000-0003-2121-4684
Dimensions author ID	0675523721.85
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62568867
is author of	Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Cardiac surgery in HIV-positive intravenous drug addicts: influence of cardiopulmonary bypass on the progression to AIDS Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature Treatment-related factors and highly active antiretroviral therapy adherence Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy Adherence to antiretroviral therapy: where are we, and where do we go from here? Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study Beyond virological suppression: the role of adherence in the late HAART era. Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009. Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study Introduction to late presentation for HIV treatment in Europe Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation Neurocognitive performance and quality of life in patients with HIV infection. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software